Evercore to Hold 8th Annual Healthcare Conference from December 2-4, 2025
Event Overview: Evercore will host its 8th annual Healthcare Conference from December 2-4, 2025, at the Loews Coral Gables Hotel in Florida, featuring over 500 industry experts from more than 200 healthcare companies.
Conference Activities: The event will include panels, fireside chats, investor meetings, and company-hosted dinners, focusing on major healthcare sectors such as Biotechnology, Pharma, and Healthcare Services.
Industry Insights: Senior leaders from Evercore emphasize the conference's role in showcasing how biopharma innovations are transforming patient outcomes and shaping the future of healthcare.
Participation Details: The conference is invite-only, with institutional investors encouraged to contact their Evercore salesperson for more information.
Trade with 70% Backtested Accuracy
Analyst Views on EVR
About EVR
About the author

- Industry Challenges: Financial stocks have collectively dropped 8.8% over the past six months due to an unpredictable interest rate and inflation environment, significantly underperforming the S&P 500's 2.8% decline, indicating investor concerns about the sector's outlook.
- State Street's Lackluster Performance: With a market cap of $35.75 billion, State Street has seen only 3.6% annual revenue growth over the past five years, and its EPS growth of 9.1% annually falls short of the peer group average, reflecting limited growth potential compared to smaller competitors.
- Raymond James's Strong Growth: Raymond James, valued at $28.26 billion, has achieved an impressive 11.7% annual revenue growth over the last five years, bolstered by share buybacks that accelerated EPS growth, showcasing management's expertise in identifying profitable investments.
- Evercore's Market Share Gains: Evercore, with a market cap of $11.93 billion, has reported a remarkable 25.9% annual revenue growth over the last two years, with EPS increasing by 50.2% annually, indicating its success in capturing market share during the current cycle.
- Nike's Disappointing Performance: Despite beating revenue and earnings expectations, Nike issued weak guidance due to inventory issues and a slowdown in North American growth, prompting downgrades from Goldman, JPMorgan, and Bank of America, reflecting market concerns about its future performance.
- RH's Poor Earnings Report: Luxury home furnishings maker RH fell short on key metrics in its fourth quarter, and its current quarter guidance was also weak, impacted by tariffs and a sluggish housing market, leading to an 18% drop in shares, although its full-year cash flow guidance improved, the overall outlook remains bleak.
- Arm's Price Target Increase: Wells Fargo raised Arm's price target from $165 to $175, with analysts optimistic about Arm's entry into the data center CPU market with its first in-house silicon offering, reiterating a buy rating, indicating strong market confidence in its competition against Intel and AMD.
- Boeing Stock Rating Upgrade: Wells Fargo upgraded Boeing's stock to buy with a price target of $250, implying over 25% upside from yesterday's close, as analysts favor Boeing's free cash flow recovery and overall turnaround under CEO Kelly Ortberg, suggesting potential returns for investors.
- Market Inflection Point: Julian Emanuel of Evercore ISI predicts that April 6, when Trump lifts the pause on attacking Iran's energy facilities, could serve as a pivotal moment for energy prices and Wall Street, potentially leading to increased market volatility.
- Oil Price Impact Analysis: Emanuel emphasizes that the bullish outlook for stocks is entirely dependent on a decline in oil prices, warning that maintaining current levels for 30 to 45 days could inflict lasting damage on the economy and markets.
- Buying Opportunity Outlook: He plans to increase stock investments if the S&P 500 drops to 6,150, reflecting a further 3% decline from current levels, viewing this as a rational buying opportunity amid market corrections.
- Tech Stock Investment Strategy: Emanuel is focusing on artificial intelligence stocks, asserting that these companies will maintain visible earnings streams even during economic slowdowns, and he anticipates the S&P 500 will reach 7,750 by year-end, representing a 22% increase from Monday's close.
- Disappointing Earnings Outlook: Nike is set to release its fiscal 2026 Q3 earnings report, with analysts expressing caution regarding performance in China, anticipating continued sales declines that could lead to further stock price drops and impact investor confidence.
- Inventory Management Improvements: Since taking over in October 2024, CEO Elliott Hill has cleared classic inventory and launched new product lines; however, the stock is still down approximately 35% from its 52-week high, reflecting market skepticism about recovery efforts.
- North American Market Growth: Nike's sales in North America rose 9% year-over-year to $5.6 billion, making it the company's largest market, but analysts note that growth is primarily driven by wholesale sales, necessitating attention to retail performance.
- Investor Confidence Wavers: While 61% of analysts maintain a buy rating on Nike, concerns arise as direct-to-consumer revenues fell 9%, leading investors to adopt a cautious stance on future growth amid increasing global economic uncertainties.
- Analyst Sentiment: As of March 24, 2026, approximately 70% of analysts maintain bullish ratings on Union Pacific Corporation (NYSE:UNP), reflecting strong market confidence in its performance, with a consensus price target of $275 implying a 14.74% upside.
- Strong Performance Growth: Evercore highlights that Union Pacific continues to demonstrate robust operational performance supported by strong volume growth and solid margins, showcasing its competitiveness in the railroad and freight transportation sector.
- Merger Outlook Impact: Analysts suggest that Union Pacific's stock may remain range-bound until clarity is achieved regarding its proposed merger with Norfolk Southern; however, if the deal closes, significant upside is projected for the stock.
- Relative Valuation Advantage: The stock is currently trading at a discount to all but one of its peers, indicating its attractiveness in the market, despite some AI stocks potentially offering greater upside potential.
- Oil Prices and Market Reaction: Oil prices are rising while stock futures are down, as President Trump's extension of the pause on attacking Iranian energy infrastructure until April 6 is interpreted as a signal for troop buildup in the Middle East, potentially affecting energy-related stocks' performance.
- Social Media Platform Pressure: JPMorgan noted that the court ruling against Meta and YouTube could force significant changes in social media platforms, leading to a nearly 8% drop in Meta's stock yesterday, which may impact user engagement and profitability, potentially eroding investor confidence.
- Netflix Price Hike Expectations: Citi anticipates Netflix will raise its outlook for 2026 following its announcement of price increases across all subscription tiers, with JPMorgan estimating an additional $1.7 billion in annual revenue for 2025, although much of this increase is already factored into sales guidance.
- Brown-Forman Merger Talks: Citi upgraded Brown-Forman from sell to hold and raised its price target from $24 to $28, while JPMorgan also moved to hold, suggesting that merger prospects will support the stock price, despite the company's historical disinterest in takeover offers.











